Skip to main content
Erschienen in: International Cancer Conference Journal 1/2012

01.03.2012 | Case report

Metastatic breast tumor due to nonfunctional parathyroid carcinoma

verfasst von: Naotaka Uchida, Kiyosuke Ishiguro, Takako Suda, Yasushi Horie, Motonobu Nishimura

Erschienen in: International Cancer Conference Journal | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Nonfunctional parathyroid carcinoma is a very rare malignant disease; only 25 cases have been reported over the last 85 years. We present a patient with a nonfunctional parathyroid carcinoma metastasis to the breast and a review of the pertinent literature. A 71-year-old woman was seen for a self-discovered mass in her left breast. She had undergone surgery 6 years previously for nonfunctional parathyroid cancer. Mammography and ultrasonography of the breast revealed an oval, circumscribed mass. Fine-needle aspiration findings were suspicious for metastasis of parathyroid carcinoma. Serum calcium and intact parathyroid hormone levels were within normal limits. We performed a partial mammary gland resection that included the tumor. Pathological analysis of the resected tumor disclosed findings consistent with parathyroid carcinoma. The nonsecretory state of the tumor was supported by negative immunoreactivity for parathyroid hormone in the tissue and lack of clinical evidence of hyperparathyroidism. To the best of our knowledge, this is the first reported case of parathyroid carcinoma metastasis to the breast. Breast metastasis of parathyroid carcinoma should be included in the differential diagnosis for a patient with a past history of parathyroid carcinoma.
Literatur
1.
Zurück zum Zitat Fujita T (1983) Primary hyperparathyroidism. Nippon Rinsho 41(supplement):823–830 Fujita T (1983) Primary hyperparathyroidism. Nippon Rinsho 41(supplement):823–830
2.
Zurück zum Zitat Schantz A, Castleman B (1973) Parathyroid carcinoma: a study of 70 cases. Cancer 31:600–605PubMedCrossRef Schantz A, Castleman B (1973) Parathyroid carcinoma: a study of 70 cases. Cancer 31:600–605PubMedCrossRef
3.
Zurück zum Zitat Sandelin K, Auer G, Bondeson L et al (1992) Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg 16:724–731PubMedCrossRef Sandelin K, Auer G, Bondeson L et al (1992) Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg 16:724–731PubMedCrossRef
4.
Zurück zum Zitat Obara T, Fujimoto Y (1991) Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg 15:738–744PubMedCrossRef Obara T, Fujimoto Y (1991) Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg 15:738–744PubMedCrossRef
5.
Zurück zum Zitat Sandelin K, Tullgren O, Farnebo LO (1994) Clinical course of metastatic parathyroid cancer. World J Surg 18:594–599PubMedCrossRef Sandelin K, Tullgren O, Farnebo LO (1994) Clinical course of metastatic parathyroid cancer. World J Surg 18:594–599PubMedCrossRef
6.
Zurück zum Zitat Cordeiro AC, Montenegro FL, Kulcsar MA et al (1998) Parathyroid carcinoma. Am J Surg 175:52–55PubMedCrossRef Cordeiro AC, Montenegro FL, Kulcsar MA et al (1998) Parathyroid carcinoma. Am J Surg 175:52–55PubMedCrossRef
7.
Zurück zum Zitat Hundahl SA, Fleming ID, Fremgen AM et al (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985–1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86:538–544PubMedCrossRef Hundahl SA, Fleming ID, Fremgen AM et al (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985–1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86:538–544PubMedCrossRef
8.
Zurück zum Zitat Busaidy NL, Jimenez C, Habra MA et al (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26:716–726PubMedCrossRef Busaidy NL, Jimenez C, Habra MA et al (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26:716–726PubMedCrossRef
9.
Zurück zum Zitat Wilkins BJ, Lewis JS Jr (2009) Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery. Head Neck Pathol 3:140–149PubMedCrossRef Wilkins BJ, Lewis JS Jr (2009) Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery. Head Neck Pathol 3:140–149PubMedCrossRef
10.
Zurück zum Zitat Nakamura Y, Kataoka H, Sakoda T et al (2010) Nonfunctional parathyroid carcinoma. Int J Clin Oncol 15:500–503PubMedCrossRef Nakamura Y, Kataoka H, Sakoda T et al (2010) Nonfunctional parathyroid carcinoma. Int J Clin Oncol 15:500–503PubMedCrossRef
11.
Zurück zum Zitat Ashkenazi D, Elmalah I, Rakover Y (2006) Concurrent nonfunctioning parathyroid carcinoma and parathyroid adenoma. Am J Otolaryngol 27:204–206PubMedCrossRef Ashkenazi D, Elmalah I, Rakover Y (2006) Concurrent nonfunctioning parathyroid carcinoma and parathyroid adenoma. Am J Otolaryngol 27:204–206PubMedCrossRef
12.
Zurück zum Zitat Gao WC, Ruan CP, Zhang JC et al (2010) Nonfunctional parathyroid carcinoma. J Cancer Res Clin Oncol 136:969–974 Gao WC, Ruan CP, Zhang JC et al (2010) Nonfunctional parathyroid carcinoma. J Cancer Res Clin Oncol 136:969–974
13.
Zurück zum Zitat Busaidy NL, Jimenez C, Habra MA et al (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26:716–726PubMedCrossRef Busaidy NL, Jimenez C, Habra MA et al (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26:716–726PubMedCrossRef
14.
Zurück zum Zitat Nielsen M, Andersen JA, Henriksen FW et al (1981) Metastases to the breast from extramammary carcinomas. Acta Pathol Microbiol Scand A 89:251–256PubMed Nielsen M, Andersen JA, Henriksen FW et al (1981) Metastases to the breast from extramammary carcinomas. Acta Pathol Microbiol Scand A 89:251–256PubMed
15.
Zurück zum Zitat Toombs BD, Kalisher L (1977) Metastatic disease to the breast: clinical, pathologic, and radiographic features. AJR Am J Roentgenol 129:673–676PubMed Toombs BD, Kalisher L (1977) Metastatic disease to the breast: clinical, pathologic, and radiographic features. AJR Am J Roentgenol 129:673–676PubMed
16.
Zurück zum Zitat Iihara M, Okamoto T, Suzuki R et al (2007) Functional parathyroid carcinoma: long-term treatment outcome and risk factor analysis. Surgery 142:936–943PubMedCrossRef Iihara M, Okamoto T, Suzuki R et al (2007) Functional parathyroid carcinoma: long-term treatment outcome and risk factor analysis. Surgery 142:936–943PubMedCrossRef
Metadaten
Titel
Metastatic breast tumor due to nonfunctional parathyroid carcinoma
verfasst von
Naotaka Uchida
Kiyosuke Ishiguro
Takako Suda
Yasushi Horie
Motonobu Nishimura
Publikationsdatum
01.03.2012
Verlag
Springer Japan
Erschienen in
International Cancer Conference Journal / Ausgabe 1/2012
Elektronische ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-011-0008-8

Weitere Artikel der Ausgabe 1/2012

International Cancer Conference Journal 1/2012 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.